Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 67: | Line 67: | ||
***[[Molecular_Playground/Taxol|Taxol Information]] | ***[[Molecular_Playground/Taxol|Taxol Information]] | ||
***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
| + | ***[[Molecular_Playground/YKL-40|YKL-40]] | ||
**Compromised Immune System | **Compromised Immune System | ||
| Line 77: | Line 78: | ||
***[[Molecular_Playground/Insulin|Insulin Information]] | ***[[Molecular_Playground/Insulin|Insulin Information]] | ||
***[[Peroxisome Proliferator-Activated Receptors]] | ***[[Peroxisome Proliferator-Activated Receptors]] | ||
| + | ***[[Molecular_Playground/YKL-40|YKL-40]] | ||
**Digestive Diseases | **Digestive Diseases | ||
| Line 90: | Line 92: | ||
**Inflammation & Rheumatoid Arthritis | **Inflammation & Rheumatoid Arthritis | ||
***[[Cyclooxygenase]] | ***[[Cyclooxygenase]] | ||
| + | ***[[Molecular_Playground/YKL-40|YKL-40]] | ||
**Metabolic Disorders | **Metabolic Disorders | ||
Revision as of 10:55, 24 September 2010
The following is a list of major pharmaceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
